PER 0.00% 10.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-28

  1. 5,245 Posts.
    lightbulb Created with Sketch. 2576
    Dilution is never good for existing SH's...but I have to agree with you "the fact that Australian Ethical Investment are prepared to buy in for approx $1mil it give me a hint of positivity."

    If it was just your standard call for some cash to keep the wages going that would have been one step closer to the cliffs edge, but Australian Ethical Investment, that's very positive and judging by the increase in buying activity and "it is quite astonishing to realise the number of non holders that all
    of the sudden came out of their holes when there is the suspect that something, maybe positive"...made me keep my shares and not sell by the 30.06.17 to offset some gains. I might have to sell something else at the end of FY2017 to offset the gains we'll have from ANP
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.